Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage

International Surgery

Volumn 85, Issue 2, 2000, Pages 124-129

  Nakatsuka, Akio ^a   Yamaguchi, Koji ^a   Chijiiwa, Kazuo ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Octreotide; Pancreatic exocrine function; Pancreatoenterostomy leakage

Indexed keywords

DRUG DERIVATIVE; GASTROINTESTINAL AGENT; HORMONE; OCTREOTIDE; SOMATOSTATIN;

ADULT; AGED; ANASTOMOSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; PANCREAS; PANCREAS DISEASE; PANCREAS JUICE; PANCREATICODUODENECTOMY; PANCREATICOJEJUNOSTOMY; POSTOPERATIVE COMPLICATION; SECRETION; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANASTOMOSIS, SURGICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL AGENTS; HORMONES; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; OCTREOTIDE; PANCREAS; PANCREATIC DISEASES; PANCREATIC JUICE; PANCREATICODUODENECTOMY; PANCREATICOJEJUNOSTOMY; POSTOPERATIVE COMPLICATIONS; SOMATOSTATIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034172762     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Magistrelli P, Mansetti R, Coppola R, Riccioni ME, Crucitti A, Nuzzo G et al. Pancreatic resection for periampullary cancer in elderly patients. Hepatogastroenterology 1998; 45: 242-7
2. Buchler MW, Friess H, Muller MW, Wheatley AM, Beger HG. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg 1995; 169: 65-70
3. Fernandez-del CC, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg 1995; 130: 295-300
4. Peter JH, Carey LC. Historical review of pancreaticoduodenectomy. Am J Surg 1991; 161: 219-25
5. Grace PA, Pitt HA, Longmire WP. Pylorus preserving pancreatoduodenectomy: an overview. Br J Surg 1990; 77: 968-74
6. Singh SM, Longmire WP, Reber HA. Surgical palliation for pancreatic cancer. Ann Surg 1990; 212: 132-9
7. Pellegrini CA, Heck CF, Raper S, Way LWS. An analysis of the reduced morbidity and mortality rates after pancreatico-duodenectomy. Arch Surg 1989; 124: 778-81
8. Trede M, Schwall G. The complications of pancreatectomy. Ann Surg 1988; 207: 39-47
9. Raptis S, Schlegel W, Lehmann E, Dollinger HC, Zoupas CH. Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism 1978; 27: 1321-8
10. Konturek SJ, Tasler J, Obtulowicz W, Coy DH, Schally AV. Effects of growth hormone release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J Clin Invest 1976; 58: 1-6
11. Bloom SR, Mortimer CH, Thomer MO, Besser GM, Hall R, Gomez-Pan A et al. Inhibition of gastrin and gastric acid secretion by growth-hormone release-inhibiting hormone. Lancet 1974; ii: 1106-9
12. Klempa I, Schwedes U, Usadel KH. Verhutung von postoperativen pankreatischen Komplikationen nach Duodeno-pankreatektomie durch Somatostatin. Chirurg 1979; 50: 427-31
13. Bauer W, Briner U, Dopfner W, Haller R, Huguenin R, Marbach P et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982; 31: 1133-40
14. Pless J, Bauer W, Briner U, Dopfner W, Marbach P, Maurer R et al. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin. Scand J Gastroenterol 1986; 21 (Suppl 119): 55-64
15. Friess H, Berger HG, Sulkowski U, Becker H, Hofbauer B, Dennlerr HJ. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 1995; 82: 1270-3
16. Pederzoli P, Bassi C, Falconi M, Camboni MG and the Italian Study Group. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 1994; 81: 265-9
17. Friess H, Klempa I, Hermanek P, Sulkowski U, Uhl W, Beger HG et al. Prophylaxis of complications after pancreatic surgery: result of a multicenter trial in Germany. Digestion 1994; 55 (Suppl 1): 35-40
18. Bassi C, Falconi M, Lombardi D, Briani G, Vesentini S, Camboni MG et al. Prophylaxis of complications after pancreatic surgery: result of a multicenter trial in Italy. Digestion 1994; 55 (Suppl 1): 41-7
19. Buchler M, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992; 163: 125-31
20. Imondi AR, Stradley RP, Wolgemuth R. Synthetic peptides in the diagnosis of exocrine pancreatic insufficiency in animals. Gut 1972; 13: 27-32
21. Lankisch PG. Exocrine pancreatic function tests. Gut 1982; 23: 777-98
22. Niederau C, Grendell JH. Diagnosis of chronic pancreatitis. Gastroenterology 1985; 26: 1257-62
23. WHO Expert Committee on Diabetes Mellitus. Second report. WHO Technical Report Series, No 646. Geneva: WHO 1980
24. Benedetti E, Coady NT, Asolati M, Dunn T, Stormoen BM, Bartholomew M et al. A prospective randomized clinical trial of perioperative treatment with octreotide in pancreas transplantation. Am J Surg 1998; 175: 14-7
25. Buchler M, Friess H. Prevention of postoperative complications following pancreatic surgery. Digestion 1993; 54 (Suppl 1): 41-6
26. Friess H, Bordihn K, Ebert M, Malfertheiner P, Kemmer T, Dennler HJ et al. Inhibition of pancreatic secretion under long-term octreotide treatment in humans. Digestion 1994; 55 (Suppl 1): 10-5
27. Freiss H, Buchler M, Meschemnoser L, Dennler HJ, Malfertheiner P. Effect of octreotide (SMS 201-995) on exocrine pancreatic function in man [abstract]. Pancreas 1989; 4: 616
28. Conway DR, Djuricin G, Prinz RA. The effect of somatostatin analogue (SMS 201-995) on pancreatic blood flow. Surgery 1988; 104: 1024-30
29. Satoh M. Experimental study on the therapeutic effects of SMS 201-995 on bile-induced acute pancreatitis in the dog [in Japanese with English abstract]. Hokkaido J Med Sci 1998; 73: 37-46